Celsion's ThermoDox Phase I trial data presented at 9th IHPBA World Congress

[News]

Celsion Corporation today announced that Dr. Thanjavur S. Ravikumar, from the Geisinger Health System and a principal investigator of the Phase I ThermoDox® dose escalation trial, gave an oral presentation at the Liver Tumors Panel session of the 9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA) in Buenos Aires, Argentina.

More... (http://www.news-medical.net/news/20100421/Celsions-ThermoDox-Phase-I-trial-data-presented-at-9th-IHPBA-World-Congress.aspx)